drugset / Trial / NCT00405704

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

NCT00405704

RandomizedParallel-groupQuadruple-blindPrevention

Summary

In this 2-year, multisite, randomized, placebo-controlled trial involving 607 children with vesicoureteral reflux that was diagnosed after a first or second febrile or symptomatic urinary tract infecton, we evaluated the efficacy of Trimethoprim-Sulfamethoxazole (TMP-SMZ) prophylaxis in preventing recurrences (primary outcome). Secondary outcomes were renal scarring, treatment failure (a composite of recurrences and scarring), and antimicrobial resistance.

Timeline

Start
2007-05
Primary completion
2013-06
Completion
2014-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sulfamethoxazole Small molecule 15 mg/kg
Comparator Trimethoprim Small molecule 3 mg/kg